Case 18 Systemic Hypertension With Dilated
Case 18 Systemic Hypertension With Dilated
Case 18 Systemic Hypertension With Dilated
Patient profile
Name : ABCD
Ward : Male Medicine Ward
Age : 59 yrs
Sex : male
Hospital : Nims hospital
PRESENTING COMPLAINTS
PAST HISTORY
Personal history
Married
Smoker (stopped now)
Non alcoholic
Family history
NiL
KNOWN ALLERGIC
NIL
Subjective evidence:
OBJECTIVE FINDINGS
PULSE RATE 89 89 92
(per min)
BLOOD PRESSURE 90/60 120/70 115/70
(mm of Hg)
TEMPERATURE 102 102 99
(degree F)
Lab investigations
Other investigation
Renal function
Ultrasonography
Assessment
GOAL OF THERAPY–
To eliminate the patient's symptoms
To focus on minimum ADRs, with maximal drug effectiveness
To focus on using minimum number of drugs
To improve QoL.
Treatment given
RDA DRUG DOSE FREQUENC DATE STARTED DATE STOPPED
Y
IV INJ.LASIX 1amp BD 25/8 29/8
IV INJ. RANTAC 5/50 BD 25/8 29/8
IV INJ. CEFONUS 1.5g BD 25/8 29/8
IV TAB. PAN 40 40 mg SOS 28/8 30/8
P/O T AB. RAMIPRIL 2.5mg OD 26/8 30/8
P/O NEBULIZATION TDS 25/8 30/8
P/O TAB. CARDIOVAS 3.125mg BD 25/8 30/8
P/O TAB. RIVOTRIL 0.5 mg HS 25/8 30/8
P/O TAB. ALDACTONE 150 mg BD 26/8 29/8
P/O TAB. DYTOR 20/50 BD 28/8 30/8
P/O SYP. MUCAINE 2 tsp TDS 29/8 30/8
GEL
P/O TAB. DIGOXIN 0.25 mg OD 29/8 30/8
P/O TAB. SPORLAC 2 tab BD 30/8 30/8
P/O TAB. OFLOX 0.2 g BD 30/8 30/8
Pharmaceutical issues
Diuretic must be reduced or discontinued with concomitant use of ramipril.
Close therapy monitoring needed as multitude of drugs are used.
Fluoroquinolones, including ofloxacin, are associated with an increased risk of
tendinitis and tendon rupture in all ages. This risk is further increased in older
patients usually over 60 years of age, in patients taking corticosteroid drugs.
Suggestion for optimization of therapy
Innate counseling
Monitoring drug side effects.
Cardiovas must not be suddenly withdrawn as this may cause bradycardia.
Signs for tendinitis must be carefully monitored.
Documentation of treatment regimen
Clinical follow up care